This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Lee BB, Villavicencio JL. Primary lymphoedema and lymphatic malformation: are they the two sides of the same coin? Eur J Vasc Endovasc Surg 2010; 39(5): 646–53.10.1016/j.ejvs.2010.01.01820176496LeeBBVillavicencioJLPrimary lymphoedema and lymphatic malformation: are they the two sides of the same coin?Eur J Vasc Endovasc Surg20103956465320176496Open DOISearch in Google Scholar
Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest 2014; 124(3): 898–904.2459027410.1172/JCI71614BrouillardPBoonLVikkulaMGenetics of lymphatic anomaliesJ Clin Invest20141243898904393825624590274Search in Google Scholar
ISL. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology 2016; 49: 170–84.29908550ISLThe diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphologyLymphology20164917084Search in Google Scholar
Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, Mansour S, Ostergaard P. The classification and diagnostic algorithm for primary lymphatic dysplasia: An update from 2010 to include molecular findings. Clin Genet 2013; 84(4): 303-14.2362185110.1111/cge.12173ConnellFCGordonKBriceGKeeleyVJefferySMortimerPSMansourSOstergaardPThe classification and diagnostic algorithm for primary lymphatic dysplasia: An update from 2010 to include molecular findingsClin Genet20138443031423621851Search in Google Scholar
Brice GW, Mansour S, Ostergaard P, Connell F, Jeffery S, Mortimer P. Milroy Disease. 2006 Apr 27 (updated 2014 Sep 25). In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® (Internet). Seattle (WA): University of Washington, Seattle; 1993-2018.BriceGWMansourSOstergaardPConnellFJefferySMortimerPMilroy Disease2006 Apr 27 (updated 2014 Sep 25)AdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKAmemiyaAGeneReviews® (Internet)Seattle (WA)University of Washington, Seattle1993-2018Search in Google Scholar
Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res 2012; 18(8): 2382–90.2235169710.1158/1078-0432.CCR-11-2303FinegoldDNBatyCJKnickelbeinKZPerschkeSNoonSECampbellDKarlssonJMHuangDKimakMALawrenceECFeingoldEMerineySDBrufskyAMFerrellREConnexin 47 mutations increase risk for secondary lymphedema following breast cancer treatmentClin Cancer Res2012188238290362566522351697Search in Google Scholar
Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 2008; 6(2): 65–8.1856492010.1089/lrb.2008.1524FinegoldDNSchachtVKimakMALawrenceECFoeldiEKarlssonJMBatyCJFerrellREHGF and MET mutations in primary and secondary lymphedemaLymphat Res Biol200862658429875018564920Search in Google Scholar
Ferrell RE, Baty CJ, Kimak MA, Karlsson JM, Lawrence EC, Franke-Snyder M, Meriney SD, Feingold E, Finegold DN. GJC2 missense mutations cause human lymphedema. Am J Hum Genet 2010; 86(6): 943–8.10.1016/j.ajhg.2010.04.01020537300FerrellREBatyCJKimakMAKarlssonJMLawrenceECFranke-SnyderMMerineySDFeingoldEFinegoldDNGJC2 missense mutations cause human lymphedemaAm J Hum Genet20108669438303206420537300Open DOISearch in Google Scholar
Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer PS, Mansour S, Schulte-Merker S, Ostergaard P. Mutation in vascular endothelial growth factor-c, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res 2013; 112(6): 956–60.2341091010.1161/CIRCRESAHA.113.300350GordonKSchulteDBriceGSimpsonMARoukensMGvan ImpelAConnellFKalidasKJefferySMortimerPSMansourSSchulte-MerkerSOstergaardPMutation in vascular endothelial growth factor-c, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedemaCirc Res201311269566023410910Search in Google Scholar
Gonzalez-Garay ML, Aldrich MB, Rasmussen JC, Guilliod R, Lapinski PE, King PD, Sevick-Muraca EM. A novel mutation in CELSR1 is associated with hereditary lymphedema. Vasc Cell 2016; 8:1.10.1186/s13221-016-0035-526855770Gonzalez-GarayMLAldrichMBRasmussenJCGuilliodRLapinskiPEKingPDSevick-MuracaEMA novel mutation in CELSR1 is associated with hereditary lymphedemaVasc Cell201681474336426855770Open DOISearch in Google Scholar
Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000; 67(6): 1382–8.1107847410.1086/316915FangJDagenaisSLEricksonRPArltMFGlynnMWGorskiJLSeaverLHGloverTWMutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndromeAm J Hum Genet200067613828128791511078474Search in Google Scholar
Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, Murday VA, Hodgson S, Keenan R, Pilz DT, Martinez-Corral I, Makinen T, Mortimer PS, Jeffery S, Trembath RC, Mansour S. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011; 43(10): 929–31.2189215810.1038/ng.923OstergaardPSimpsonMAConnellFCStewardCGBriceGWoollardWJDafouDKiloTSmithsonSLuntPMurdayVAHodgsonSKeenanRPilzDTMartinez-CorralIMakinenTMortimerPSJefferySTrembathRCMansourSMutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)Nat Genet201143109293121892158Search in Google Scholar
Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, teijlen PM, Fryns JP, Van Steensel MA, Vikkula M. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 2003; 72(6): 1470–8.10.1086/37561412740761IrrthumADevriendtKChitayatDMatthijsGGladeCteijlenPMFrynsJPVan SteenselMAVikkulaMMutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasiaAm J Hum Genet200372614708118030712740761Open DOISearch in Google Scholar
Ostergaard P, Simpson MA, Mendola A, Vasudevan P, Connell FC, van Impel A, Moore AT, Loeys BL, Ghalamkarpour A, Onoufriadis A, Martinez-Corral I, Devery S, Leroy JG, van Laer L, Singer A, Bialer MG, McEntagart M, Quarrell O, Brice G, Trembath RC, Schulte-Merker S, Makinen T, Vikkula M, Mortimer PS, Mansour S, Jeffery S. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. Am J Hum Genet 2012; 90(2): 356–62.10.1016/j.ajhg.2011.12.01822284827OstergaardPSimpsonMAMendolaAVasudevanPConnellFCvan ImpelAMooreATLoeysBLGhalamkarpourAOnoufriadisAMartinez-CorralIDeverySLeroyJGvan LaerLSingerABialerMGMcEntagartMQuarrellOBriceGTrembathRCSchulte-MerkerSMakinenTVikkulaMMortimerPSMansourSJefferySMutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathyAm J Hum Genet201290235662327666022284827Open DOISearch in Google Scholar
Brice G, Ostergaard P, Jeffery S, Gordon K, Mortimer P, Mansour S. A novel mutation in GJA1 causing oculodentodigital syndrome and primary lymphoedema in a three generation family. Clin Genet 2013; 84(4): 378–81.10.1111/cge.12158BriceGOstergaardPJefferySGordonKMortimerPMansourSA novel mutation in GJA1 causing oculodentodigital syndrome and primary lymphoedema in a three generation familyClin Genet20138443788123550541Open DOISearch in Google Scholar
Martin-Almedina S, Martinez-Corral I, Holdhus R, Vicente A, Fotiou E, Lin S, Petersen K, Simpson MA, Hoischen A, Gilissen C, Jeffery H, Atton G, Karapouliou C, Brice G, Gordon K, Wiseman JW, Wedin M, Rockson SG, Jeffery S, Mortimer PS, Snyder MP, Berland S, Mansour S, Makinen T, Ostergaard P. EPHB4 kinase – inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. J Clin Invest 2016; 126(8): 3080-8.10.1172/JCI8579427400125Martin-AlmedinaSMartinez-CorralIHoldhusRVicenteAFotiouELinSPetersenKSimpsonMAHoischenAGilissenCJefferyHAttonGKarapouliouCBriceGGordonKWisemanJWWedinMRocksonSGJefferySMortimerPSSnyderMPBerlandSMansourSMakinenTOstergaardPEPHB4 kinase – inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalisJ Clin Invest2016126830808496630127400125Open DOISearch in Google Scholar
Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002; 70(6): 1555–63.1199226110.1086/340847TartagliaMKalidasKShawASongXMusatDLvan der BurgtIBrunnerHGBertolaDRCrosbyAIonAKucherlapatiRSJefferySPattonMAGelbBDPTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneityAm J Hum Genet200270615556337914211992261Search in Google Scholar
Morcaldi G, Bellini T, Rossi C, Maghnie M, Boccardo F, Bonioli E, Bellini C. Lymphodysplasia and KRAS mutation: a case report and literature review. Lymphology 2015; 48(3): 121–7.26939159MorcaldiGBelliniTRossiCMaghnieMBoccardoFBonioliEBelliniCLymphodysplasia and KRAS mutation: a case report and literature reviewLymphology20154831217Search in Google Scholar
Ekvall S, Wilbe M, Dahlgren J, Legius E, van Haeringen A, Westphal O, Annerén G, Bondeson ML. Mutation in NRAS in familial Noonan syndrome – case report and review of the literature. BMC Med Genet 2015; 16: 95.10.1186/s12881-015-0239-126467218EkvallSWilbeMDahlgrenJLegiusEvan HaeringenAWestphalOAnnerénGBondesonMLMutation in NRAS in familial Noonan syndrome – case report and review of the literatureBMC Med Genet20151695460701326467218Open DOISearch in Google Scholar
Milosavljević D, Overwater E, Tamminga S, de Boer K, Elting MW, van Hoorn ME, Rinne T, Houweling AC. Two cases of RIT1 associated Noonan syndrome: further delineation of the clinical phenotype and review of the literature. Am J Med Genet Part A 2016; 170(7):1874–80.10.1002/ajmg.a.37657MilosavljevićDOverwaterETammingaSde BoerKEltingMWvan HoornMERinneTHouwelingACTwo cases of RIT1 associated Noonan syndrome: further delineation of the clinical phenotype and review of the literatureAm J Med Genet Part A2016170718748027109146Open DOISearch in Google Scholar
Allanson JE, Roberts AE. Noonan Syndrome. (2001 Nov 15 (updated 2016 Feb 25). In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® (Internet). Seattle (WA): University of Washington, Seattle; 1993-2018.AllansonJERobertsAENoonan Syndrome (2001 Nov 15 (updated 2016 Feb 25). InAdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKAmemiyaAGeneReviews® (Internet)Seattle (WA)University of Washington, Seattle1993-2018Search in Google Scholar
Hanson HL, Wilson MJ, Short JP, Chioza BA, Crosby AH, Nash RM, Marks KJ, Mansour S. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23. Am J Med Genet A 2014; 164A(4): 1003–9.24458550HansonHLWilsonMJShortJPChiozaBACrosbyAHNashRMMarksKJMansourSGermline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23Am J Med Genet A2014164A41003–910.1002/ajmg.a.3637524458550Search in Google Scholar
Lo IFM, Brewer C, Shannon N, Shorto J, Tang B, Black G, Soo MT, Ng DK, Lam ST, Kerr B. Severe neonatal manifestations of Costello syndrome. J Med Genet 2008; 45(3): 167–71.18039947LoIFMBrewerCShannonNShortoJTangBBlackGSooMTNgDKLamSTKerrBSevere neonatal manifestations of Costello syndromeJ Med Genet20084531677110.1136/jmg.2007.05441118039947Search in Google Scholar
Joyce S, Gordon K, Brice G, Ostergaard P, Nagaraja R, Short J, Moore S, Mortimer P, Mansour S. The lymphatic phenotype in Noonan and cardiofaciocutaneous syndrome. Eur J Hum Genet 2016; 24(5): 690–96.10.1038/ejhg.2015.175JoyceSGordonKBriceGOstergaardPNagarajaRShortJMooreSMortimerPMansourSThe lymphatic phenotype in Noonan and cardiofaciocutaneous syndromeEur J Hum Genet201624569096493008426242988Open DOISearch in Google Scholar
Au AC, Hernandez PA, Lieber E, Nadroo AM, Shen YM, Kelley KA, Gelb BD, Diaz GA. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am J Hum Genet 2010; 87(3): 436–44.10.1016/j.ajhg.2010.08.00820826270AuACHernandezPALieberENadrooAMShenYMKelleyKAGelbBDDiazGAProtein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humansAm J Hum Genet201087343644293333620826270Open DOISearch in Google Scholar
Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, Prescott TE, Schroor EJ, Verheij JB, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, Hennekam RC. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 2009; 41(12): 1272–74.1993566410.1038/ng.484AldersMHoganBMGjiniESalehiFAl-GazaliLHennekamEAHolmbergEEMannensMMMulderMFOfferhausGJPrescottTESchroorEJVerheijJBWitteMZwijnenburgPJVikkulaMSchulte-MerkerSHennekamRCMutations in CCBE1 cause generalized lymph vessel dysplasia in humansNat Genet2009411212727419935664Search in Google Scholar
Alders M, Al-Gazali L, Cordeiro I, Dallapiccola B, Garavelli L, Tuysuz B, Salehi F, Haagmans MA, Mook OR, Majoie CB, Mannens MM, Hennekam RC. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome. Hum Genet 2014; 133(9): 1161–67.10.1007/s00439-014-1456-yAldersMAl-GazaliLCordeiroIDallapiccolaBGaravelliLTuysuzBSalehiFHaagmansMAMookORMajoieCBMannensMMHennekamRCHennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndromeHum Genet2014133911616724913602Open DOISearch in Google Scholar
Fotiou E, Martin-Almedina S, Simpson MA, Lin S, Gordon K, Brice G, Atton G, Jeffery I, Rees DC, Mignot C, Vogt J, Homfray T, Snyder MP, Rockson SG, Jeffery S, Mortimer PS, Mansour S, Ostergaard P. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun 2015; 6:8085.10.1038/ncomms908526333996FotiouEMartin-AlmedinaSSimpsonMALinSGordonKBriceGAttonGJefferyIReesDCMignotCVogtJHomfrayTSnyderMPRocksonSGJefferySMortimerPSMansourSOstergaardPNovel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalisNat Commun201568085456831626333996Open DOISearch in Google Scholar
Brouillard P, Dupont L, Helaers R, Coulie R, Tiller GE, Peeden J, Colige A, Vikkula M. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia–lymphedema syndrome 3. Hum Mol Genet 2017; 26(21): 4095-04.2898535310.1093/hmg/ddx297BrouillardPDupontLHelaersRCoulieRTillerGEPeedenJColigeAVikkulaMLoss of ADAMTS3 activity causes Hennekam lymphangiectasia–lymphedema syndrome 3Hum Mol Genet2017262140950428985353Search in Google Scholar
Döffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israël A, Courtois G, Casanova JL. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kB signaling. Nat Genet 2001; 27 (3): 277–85.10.1038/85837DöffingerRSmahiABessiaCGeissmannFFeinbergJDurandyABodemerCKenwrickSDupuis-GirodSBlancheSWoodPRabiaSHHeadonDJOverbeekPALe DeistFHollandSMBelaniKKumararatneDSFischerAShapiroRConleyMEReimundEKalhoffHAbinunMMunnichAIsraëlACourtoisGCasanovaJLX-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kB signalingNat Genet20012732778511242109Open DOISearch in Google Scholar
Macmurdo CF, Wooderchak-Donahue W, Bayrak-Toydemir P, Le J, Wallenstein MB, Milla C, Teng JM, Bernstein JA, Stevenson DA. RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome. Am J Med Genet A. 2016; 170(6): 1450-54.10.1002/ajmg.a.3761326969842MacmurdoCFWooderchak-DonahueWBayrak-ToydemirPLeJWallensteinMBMillaCTengJMBernsteinJAStevensonDARASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndromeAm J Med Genet A2016170614505426969842Open DOISearch in Google Scholar
Burrows PE, Gonzalez-Garay ML, Rasmussen JC, Aldrich MB, Guilliod R, Maus EA, Fife CE, Kwon S, Lapinski PE, King PD, Sevick-Muraca EM. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci U S A. 2013; 110(21): 8621-26.10.1073/pnas.122272211023650393BurrowsPEGonzalez-GarayMLRasmussenJCAldrichMBGuilliodRMausEAFifeCEKwonSLapinskiPEKingPDSevick-MuracaEMLymphatic abnormalities are associated with RASA1 gene mutations in mouse and manProc Natl Acad Sci U S A201311021862126366667523650393Open DOISearch in Google Scholar
Ma GC, Liu CS, Chang SP, Yeh KT, Ke YY, Chen TH, Wang BB, Kuo SJ, Shih JC, Chen M. A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy. Prenat Diagn. 2008; 28(11): 1057-63.10.1002/pd.213018973153MaGCLiuCSChangSPYehKTKeYYChenTHWangBBKuoSJShihJCChenMA recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapyPrenat Diagn2008281110576318973153Open DOISearch in Google Scholar
Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovée JV, Rialon KL, Guevara CJ, Alomari AI, Greene AK, Fishman SJ, Kozakewich HP, Maclellan RA, Mulliken JB, Rahbar R, Spencer SA, Trenor CC 3rd, Upton J, Zurakowski D, Perkins JA, Kirsh A, Bennett JT, Dobyns WB, Kurek KC, Warman ML, McCarroll SA, Murillo R. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015;166(4): 1048-54.e1-5.10.1016/j.jpeds.2014.12.06925681199LuksVLKamitakiNViveroMPUllerWRabRBovéeJVRialonKLGuevaraCJAlomariAIGreeneAKFishmanSJKozakewichHPMaclellanRAMullikenJBRahbarRSpencerSATrenorCC3rdUptonJZurakowskiDPerkinsJAKirshABennettJTDobynsWBKurekKCWarmanMLMcCarrollSAMurilloRLymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CAJ Pediatr20151664104854e1-5449865925681199Open DOISearch in Google Scholar
Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, Turner J, Cannons JL, Bick D, Blakemore L, Blumhorst C, Brockmann K, Calder P, Cherman N, Deardorff MA, Everman DB, Golas G, Greenstein RM, Kato BM, Keppler-Noreuil KM, Kuznetsov SA, Miyamoto RT, Newman K, Ng D, O’Brien K, Rothenberg S, Schwartzentruber DJ, Singhal V, Tirabosco R, Upton J, Wientroub S, Zackai EH, Hoag K, Whitewood-Neal T, Robey PG, Schwartzberg PL, Darling TN, Tosi LL, Mullikin JC, Biesecker LG. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365(7): 611-19.10.1056/NEJMoa110401721793738LindhurstMJSappJCTeerJKJohnstonJJFinnEMPetersKTurnerJCannonsJLBickDBlakemoreLBlumhorstCBrockmannKCalderPChermanNDeardorffMAEvermanDBGolasGGreensteinRMKatoBMKeppler-NoreuilKMKuznetsovSAMiyamotoRTNewmanKNgDO’BrienKRothenbergSSchwartzentruberDJSinghalVTiraboscoRUptonJWientroubSZackaiEHHoagKWhitewood-NealTRobeyPGSchwartzbergPLDarlingTNTosiLLMullikinJCBieseckerLGA mosaic activating mutation in AKT1 associated with the Proteus syndromeN Engl J Med2011365761119317041321793738Open DOISearch in Google Scholar
Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20301295AdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKAmemiyaAGeneReviewsSeattle (WA)University of Washington, Seattle1993-2018Available fromhttp://www.ncbi.nlm.nih.gov/pubmed/20301295Search in Google Scholar
